STOCK TITAN

[Form 4] Kestra Medical Technologies, Ltd. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Asbury Automotive Group (ABG) reported on Form 8-K that on 21 Jul 2025 it closed the $1.45 billion purchase of The Herb Chambers Companies, adding 33 dealerships, 52 franchises and three collision centres to its platform.

The acquisition was financed by: (1) a new $546.5 million, 10-year real-estate term loan with Wells Fargo and other lenders (SOFR + 2% or Base Rate + 1%, 118 monthly amortisation payments of $2.28 million starting 1 Sep 2025, balloon at maturity, secured by first-priority property liens, subject to leverage and fixed-charge covenants); (2) a $750 million upsizing of ABG’s Senior Credit Facility with Bank of America and syndicate lenders; and (3) available cash.

The term loan and expanded revolver are guaranteed by the parent and certain subsidiaries and include customary affirmative, negative and cross-default provisions. Required historical and pro-forma financial statements will be filed within 71 days. A press release announcing completion is furnished as Exhibit 99.1.

Asbury Automotive Group (ABG) ha comunicato tramite il modulo 8-K che il 21 luglio 2025 ha completato l'acquisizione da 1,45 miliardi di dollari di The Herb Chambers Companies, aggiungendo 33 concessionarie, 52 franchise e tre centri di riparazione collisioni alla sua piattaforma.

L'acquisizione è stata finanziata tramite: (1) un nuovo prestito a termine immobiliare decennale da 546,5 milioni di dollari con Wells Fargo e altri finanziatori (SOFR + 2% o tasso base + 1%, 118 pagamenti mensili di ammortamento da 2,28 milioni di dollari a partire dal 1° settembre 2025, pagamento finale alla scadenza, garantito da ipoteche di primo grado sugli immobili, soggetto a vincoli di leva finanziaria e di copertura delle spese fisse); (2) un incremento di 750 milioni di dollari della linea di credito senior di ABG con Bank of America e sindacato di finanziatori; e (3) liquidità disponibile.

Il prestito a termine e la linea di credito ampliata sono garantiti dalla capogruppo e da alcune controllate e includono le consuete clausole affirmative, negative e di cross-default. I bilanci storici e pro-forma richiesti saranno depositati entro 71 giorni. Un comunicato stampa che annuncia il completamento è allegato come Exhibit 99.1.

Asbury Automotive Group (ABG) informó mediante el Formulario 8-K que el 21 de julio de 2025 cerró la compra de 1.450 millones de dólares de The Herb Chambers Companies, incorporando 33 concesionarios, 52 franquicias y tres centros de colisiones a su plataforma.

La adquisición fue financiada con: (1) un nuevo préstamo a plazo inmobiliario a 10 años de 546,5 millones de dólares con Wells Fargo y otros prestamistas (SOFR + 2% o tasa base + 1%, 118 pagos mensuales de amortización de 2,28 millones de dólares comenzando el 1 de septiembre de 2025, pago global al vencimiento, garantizado por gravámenes prioritarios sobre propiedades, sujeto a convenios de apalancamiento y cargos fijos); (2) una ampliación de 750 millones de dólares de la línea de crédito senior de ABG con Bank of America y un sindicato de prestamistas; y (3) efectivo disponible.

El préstamo a plazo y la línea de crédito ampliada están garantizados por la matriz y ciertas subsidiarias e incluyen las disposiciones habituales afirmativas, negativas y de incumplimiento cruzado. Los estados financieros históricos y proforma requeridos se presentarán dentro de 71 días. Un comunicado de prensa anunciando la finalización se adjunta como Exhibit 99.1.

Asbury Automotive Group (ABG)는 2025년 7월 21일 Form 8-K를 통해 The Herb Chambers Companies를 14억 5천만 달러에 인수 완료했다고 보고했으며, 이를 통해 33개의 딜러십, 52개의 프랜차이즈, 3개의 충돌 센터가 플랫폼에 추가되었습니다.

이번 인수는 다음과 같이 자금 조달되었습니다: (1) Wells Fargo 및 기타 대출기관과 체결한 5억 4,650만 달러, 10년 만기 부동산 담보 대출(SOFR + 2% 또는 기준금리 + 1%, 2025년 9월 1일부터 월 228만 달러씩 118회 분할 상환, 만기 시 일시 상환, 1순위 부동산 담보 제공, 레버리지 및 고정비용 약정 적용); (2) Bank of America 및 신디케이트 대출기관과 함께한 ABG의 시니어 신용 시설 7억 5천만 달러 증액; (3) 가용 현금.

이 부동산 담보 대출과 확대된 리볼빙 신용 한도는 모회사 및 일부 자회사가 보증하며, 일반적인 긍정적, 부정적, 교차 채무 불이행 조항이 포함되어 있습니다. 요구된 과거 및 프로포마 재무제표는 71일 이내에 제출될 예정입니다. 완료를 알리는 보도 자료는 Exhibit 99.1로 첨부되었습니다.

Asbury Automotive Group (ABG) a déclaré dans le formulaire 8-K que le 21 juillet 2025, elle a finalisé l'achat de The Herb Chambers Companies pour 1,45 milliard de dollars, ajoutant 33 concessions, 52 franchises et trois centres de carrosserie à sa plateforme.

L'acquisition a été financée par : (1) un nouveau prêt immobilier à terme de 546,5 millions de dollars sur 10 ans avec Wells Fargo et d'autres prêteurs (SOFR + 2 % ou taux de base + 1 %, 118 paiements mensuels d'amortissement de 2,28 millions de dollars à partir du 1er septembre 2025, paiement global à l'échéance, garanti par des privilèges immobiliers de premier rang, soumis à des clauses de levier financier et de charges fixes) ; (2) une augmentation de 750 millions de dollars de la facilité de crédit senior d'ABG auprès de Bank of America et d'un syndicat de prêteurs ; et (3) des liquidités disponibles.

Le prêt à terme et la ligne de crédit élargie sont garantis par la société mère et certaines filiales et comprennent les clauses habituelles positives, négatives et de défaut croisé. Les états financiers historiques et pro forma requis seront déposés dans les 71 jours. Un communiqué de presse annonçant la finalisation est fourni en annexe 99.1.

Asbury Automotive Group (ABG) gab im Formular 8-K bekannt, dass es am 21. Juli 2025 den 1,45 Milliarden Dollar Kauf von The Herb Chambers Companies abgeschlossen hat und damit 33 Autohäuser, 52 Franchisebetriebe und drei Karosseriewerkstätten zu seiner Plattform hinzufügte.

Die Übernahme wurde finanziert durch: (1) einen neuen 546,5 Millionen Dollar, 10-jährigen Immobilien-Tilgungsdarlehen mit Wells Fargo und weiteren Kreditgebern (SOFR + 2 % oder Basiszinssatz + 1 %, 118 monatliche Tilgungszahlungen von 2,28 Millionen Dollar ab dem 1. September 2025, Schlussrate bei Fälligkeit, besichert durch vorrangige Grundschulden, unterliegt Verschuldungs- und Fixkostenvereinbarungen); (2) eine 750 Millionen Dollar Aufstockung der Senior-Kreditfazilität von ABG bei Bank of America und einem Kreditgeberkonsortium; sowie (3) verfügbare liquide Mittel.

Das Term-Darlehen und der erweiterte revolvierende Kredit werden von der Muttergesellschaft und bestimmten Tochtergesellschaften garantiert und enthalten übliche positive, negative und Cross-Default-Klauseln. Die erforderlichen historischen und Pro-forma-Finanzberichte werden innerhalb von 71 Tagen eingereicht. Eine Pressemitteilung zur Bekanntgabe des Abschlusses ist als Exhibit 99.1 beigefügt.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Transformative $1.45 bn buy adds 33 dealerships; financing mix locks in long-dated real-estate debt.

Deal scope: ABG’s acquisition instantly deepens its Northeast presence and lifts its dealership count by ~20%. Goodwill allocation ($750 m) signals strong earnings expectations and limited identifiable intangibles.
Funding: Combining a fixed-asset-backed term loan with an upsized revolving floorplan spreads risk and preserves liquidity for working capital. Ten-year maturity reduces near-term refinancing pressure.
Strategic fit: Herb Chambers’ luxury mix aligns with ABG’s focus on higher-margin brands, potentially raising average gross profit per unit. Management retains flexibility to divest under-performing rooftops given asset-level collateral.

TL;DR: Leverage rises sharply; covenant headroom depends on swift integration and stable SAAR.

Debt impact: New borrowings exceed $1.3 bn, likely pushing lease-adjusted leverage above 4×. While the real-estate loan is amortising, principal payments start in FY25Q3, pressuring cash flow.
Covenants: Fixed-charge coverage and leverage tests mirror the Senior Facility, limiting dividend flexibility and further M&A. Cross-defaults heighten contagion risk.
Mitigants: Property collateral and staggered amortisation reduce loss-given-default; diversified lender group spreads refinancing options. Overall credit posture shifts to moderately higher risk but remains serviceable if post-deal synergies materialise.

Asbury Automotive Group (ABG) ha comunicato tramite il modulo 8-K che il 21 luglio 2025 ha completato l'acquisizione da 1,45 miliardi di dollari di The Herb Chambers Companies, aggiungendo 33 concessionarie, 52 franchise e tre centri di riparazione collisioni alla sua piattaforma.

L'acquisizione è stata finanziata tramite: (1) un nuovo prestito a termine immobiliare decennale da 546,5 milioni di dollari con Wells Fargo e altri finanziatori (SOFR + 2% o tasso base + 1%, 118 pagamenti mensili di ammortamento da 2,28 milioni di dollari a partire dal 1° settembre 2025, pagamento finale alla scadenza, garantito da ipoteche di primo grado sugli immobili, soggetto a vincoli di leva finanziaria e di copertura delle spese fisse); (2) un incremento di 750 milioni di dollari della linea di credito senior di ABG con Bank of America e sindacato di finanziatori; e (3) liquidità disponibile.

Il prestito a termine e la linea di credito ampliata sono garantiti dalla capogruppo e da alcune controllate e includono le consuete clausole affirmative, negative e di cross-default. I bilanci storici e pro-forma richiesti saranno depositati entro 71 giorni. Un comunicato stampa che annuncia il completamento è allegato come Exhibit 99.1.

Asbury Automotive Group (ABG) informó mediante el Formulario 8-K que el 21 de julio de 2025 cerró la compra de 1.450 millones de dólares de The Herb Chambers Companies, incorporando 33 concesionarios, 52 franquicias y tres centros de colisiones a su plataforma.

La adquisición fue financiada con: (1) un nuevo préstamo a plazo inmobiliario a 10 años de 546,5 millones de dólares con Wells Fargo y otros prestamistas (SOFR + 2% o tasa base + 1%, 118 pagos mensuales de amortización de 2,28 millones de dólares comenzando el 1 de septiembre de 2025, pago global al vencimiento, garantizado por gravámenes prioritarios sobre propiedades, sujeto a convenios de apalancamiento y cargos fijos); (2) una ampliación de 750 millones de dólares de la línea de crédito senior de ABG con Bank of America y un sindicato de prestamistas; y (3) efectivo disponible.

El préstamo a plazo y la línea de crédito ampliada están garantizados por la matriz y ciertas subsidiarias e incluyen las disposiciones habituales afirmativas, negativas y de incumplimiento cruzado. Los estados financieros históricos y proforma requeridos se presentarán dentro de 71 días. Un comunicado de prensa anunciando la finalización se adjunta como Exhibit 99.1.

Asbury Automotive Group (ABG)는 2025년 7월 21일 Form 8-K를 통해 The Herb Chambers Companies를 14억 5천만 달러에 인수 완료했다고 보고했으며, 이를 통해 33개의 딜러십, 52개의 프랜차이즈, 3개의 충돌 센터가 플랫폼에 추가되었습니다.

이번 인수는 다음과 같이 자금 조달되었습니다: (1) Wells Fargo 및 기타 대출기관과 체결한 5억 4,650만 달러, 10년 만기 부동산 담보 대출(SOFR + 2% 또는 기준금리 + 1%, 2025년 9월 1일부터 월 228만 달러씩 118회 분할 상환, 만기 시 일시 상환, 1순위 부동산 담보 제공, 레버리지 및 고정비용 약정 적용); (2) Bank of America 및 신디케이트 대출기관과 함께한 ABG의 시니어 신용 시설 7억 5천만 달러 증액; (3) 가용 현금.

이 부동산 담보 대출과 확대된 리볼빙 신용 한도는 모회사 및 일부 자회사가 보증하며, 일반적인 긍정적, 부정적, 교차 채무 불이행 조항이 포함되어 있습니다. 요구된 과거 및 프로포마 재무제표는 71일 이내에 제출될 예정입니다. 완료를 알리는 보도 자료는 Exhibit 99.1로 첨부되었습니다.

Asbury Automotive Group (ABG) a déclaré dans le formulaire 8-K que le 21 juillet 2025, elle a finalisé l'achat de The Herb Chambers Companies pour 1,45 milliard de dollars, ajoutant 33 concessions, 52 franchises et trois centres de carrosserie à sa plateforme.

L'acquisition a été financée par : (1) un nouveau prêt immobilier à terme de 546,5 millions de dollars sur 10 ans avec Wells Fargo et d'autres prêteurs (SOFR + 2 % ou taux de base + 1 %, 118 paiements mensuels d'amortissement de 2,28 millions de dollars à partir du 1er septembre 2025, paiement global à l'échéance, garanti par des privilèges immobiliers de premier rang, soumis à des clauses de levier financier et de charges fixes) ; (2) une augmentation de 750 millions de dollars de la facilité de crédit senior d'ABG auprès de Bank of America et d'un syndicat de prêteurs ; et (3) des liquidités disponibles.

Le prêt à terme et la ligne de crédit élargie sont garantis par la société mère et certaines filiales et comprennent les clauses habituelles positives, négatives et de défaut croisé. Les états financiers historiques et pro forma requis seront déposés dans les 71 jours. Un communiqué de presse annonçant la finalisation est fourni en annexe 99.1.

Asbury Automotive Group (ABG) gab im Formular 8-K bekannt, dass es am 21. Juli 2025 den 1,45 Milliarden Dollar Kauf von The Herb Chambers Companies abgeschlossen hat und damit 33 Autohäuser, 52 Franchisebetriebe und drei Karosseriewerkstätten zu seiner Plattform hinzufügte.

Die Übernahme wurde finanziert durch: (1) einen neuen 546,5 Millionen Dollar, 10-jährigen Immobilien-Tilgungsdarlehen mit Wells Fargo und weiteren Kreditgebern (SOFR + 2 % oder Basiszinssatz + 1 %, 118 monatliche Tilgungszahlungen von 2,28 Millionen Dollar ab dem 1. September 2025, Schlussrate bei Fälligkeit, besichert durch vorrangige Grundschulden, unterliegt Verschuldungs- und Fixkostenvereinbarungen); (2) eine 750 Millionen Dollar Aufstockung der Senior-Kreditfazilität von ABG bei Bank of America und einem Kreditgeberkonsortium; sowie (3) verfügbare liquide Mittel.

Das Term-Darlehen und der erweiterte revolvierende Kredit werden von der Muttergesellschaft und bestimmten Tochtergesellschaften garantiert und enthalten übliche positive, negative und Cross-Default-Klauseln. Die erforderlichen historischen und Pro-forma-Finanzberichte werden innerhalb von 71 Tagen eingereicht. Eine Pressemitteilung zur Bekanntgabe des Abschlusses ist als Exhibit 99.1 beigefügt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Webster Brian Daniel

(Last) (First) (Middle)
C/O KESTRA MEDICAL TECHNOLOGIES, LTD.
3933 LAKE WASHINGTON BLVD NE, SUITE 200

(Street)
KIRKLAND WA 98033

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
KESTRA MEDICAL TECHNOLOGIES, LTD. [ KMTS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
See Remarks
3. Date of Earliest Transaction (Month/Day/Year)
07/17/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares 07/17/2025 A 88,235(1) A $0.00 397,577 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Options (2) (2) 03/06/2035 Common Shares 1,780,000 1,780,000 D
Explanation of Responses:
1. Represents restricted stock units ("RSU") that entitle the Reporting Person to receive, at settlement, one common share of Kestra Medical Technologies, Ltd. Subject to the Reporting Person's continued service, the RSUs will vest 29,333 on July 17, 2026, 29,333 on July 17, 2027 and 29,334 on July 17, 2028.
2. Includes 1,068,000 fully vested options and 712,000 options that will vest as follows: 356,000 of such options will vest on March 6, 2026, and the remaining 356,000 will vest monthly over the following year.
Remarks:
President and Chief Executive Officer
/s/ Brian Daniel Webster 07/21/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How much did Asbury Automotive Group (ABG) pay for The Herb Chambers Companies?

Approximately $1.45 billion, including $750 m goodwill, $610 m real estate and $85 m inventory/fixed assets.

How is ABG financing the Herb Chambers acquisition?

Primarily through a $546.5 m real-estate term loan, a $750 m expansion of its Senior Credit Facility, and cash on hand.

What are the key terms of the new real-estate term loan?

10-year maturity, SOFR + 2% or Base Rate + 1% interest, 118 monthly principal payments of $2.28 m starting 1 Sep 2025.

When will ABG file financial statements for the acquired business?

Within 71 days of the 8-K filing date, as required under Item 9.01.

How many dealerships did ABG add through this transaction?

The deal adds 33 dealerships, 52 franchises and three collision centers.
KESTRA MED TECHNOLOGIES LTD

NASDAQ:KMTS

KMTS Rankings

KMTS Latest News

KMTS Latest SEC Filings

KMTS Stock Data

792.31M
10.00M
6.32%
50.37%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
KIRKLAND